Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Diabetes Obes Metab. 2019 Mar 20;21(5):1088–1100. doi: 10.1111/dom.13641

Figure 2.

Figure 2.

Genetic background for obesity resulting in CVD progression in three main stages. These include metabolic derangements due to genetic, non-genetic, dietary and lifestyle interactions; the development of cardiometabolic syndromic traits leading to fatty liver disease and inflammatory microbiome; and ultimately leading to vascular dysfunction and atherosclerotic plaque formation.